NutriBand (NTRB) Cash & Equivalents (2016 - 2026)

NutriBand has disclosed Cash & Equivalents across 11 years of filings, most recently posting $4.6 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $4.6 million, up 6.1% year-over-year; the trailing twelve-month figure through Jan 2026 was $4.6 million (up 6.1% YoY), and the FY2026 annual result was $4.6 million, up 6.1% from the prior year.
• Cash & Equivalents came in at $4.6 million for Q1 2026 at NutriBand, down from $5.3 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $8.3 million in Q2 2024 to a low of $492942.0 in Q1 2024.
• The 5-year median for Cash & Equivalents is $4.0 million (2022), against an average of $4.0 million.
• Across the five-year window, Cash & Equivalents soared 3118.48% in 2022 and plunged 75.17% in 2024, its largest moves.
• NutriBand's Cash & Equivalents stood at $2.8 million in 2022, then tumbled by 55.07% to $1.3 million in 2023, then jumped by 350.33% to $5.7 million in 2024, then fell by 6.77% to $5.3 million in 2025, then fell by 13.88% to $4.6 million in 2026.
• The last three Cash & Equivalents figures came in at $4.6 million (Q1 2026), $5.3 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.